Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Altimmune Inc (NQ: ALT ) 6.740 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Altimmune Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names October 11, 2024 The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's dominance while addressing scalability and pricing concerns. Via Benzinga 1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc) September 17, 2024 Telemedicine once seemed like it was going to revolutionize healthcare. Via The Motley Fool Decoding 4 Analyst Evaluations For Altimmune August 22, 2024 Via Benzinga 3 Promising Biotech Stocks for the Long-Term: August 2024 August 13, 2024 Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few. Via InvestorPlace The 7 Best Under $10 Stocks to Buy in August 2024 August 11, 2024 Buying low-priced stocks carries risk, but lower interest rates may lower the risk premium on these best stocks under $10. Via InvestorPlace ALT Stock Earnings: Altimmune Misses EPS for Q2 2024 August 08, 2024 ALT stock results show that Altimmune missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Forecasting The Future: 5 Analyst Projections For Altimmune June 21, 2024 Via Benzinga How Is The Market Feeling About Altimmune? June 03, 2024 Via Benzinga Prediction: This Weight Loss Stock Will Be Acquired Within the Next Year August 09, 2024 Altimmune is a little-known pharmaceutical company looking to disrupt the weight loss space. Via The Motley Fool Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now. August 02, 2024 The popularity surrounding weight loss drugs such as Mounjaro and Ozempic has brought Eli Lilly and Novo Nordisk newfound growth. Via The Motley Fool Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs? July 20, 2024 At least one of the pair has a credible shot at finding a home in the market. Via The Motley Fool 3 Undervalued Biotech Stocks With Breakout Potential July 19, 2024 Invest in these three undervalued biotech stocks with double-digit upside ahead driven by cutting-edge healthcare advancements Via InvestorPlace Forget Boring Diversification! 3 Wild-Card Stocks to Spice Up Your Portfolio July 17, 2024 These three wild-card stocks will spice up your portfolio in ways boring diversification never could, so read on. Via InvestorPlace Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics July 10, 2024 Both competitors have promising lead programs, and enough cash, too. Via The Motley Fool 7 Bullish Stock Picks With the Potential to Turn $5K Into $50K July 09, 2024 These high-potential stock picks each have 10X potential moving forward and are well worth understanding despite high prices in some cases. Via InvestorPlace The 7 Best Under $10 Stocks to Buy in July 2024 July 06, 2024 We’re finding big opportunities in some of the best stocks under $10 a share. In fact, here are seven you may want to jump into now. Via InvestorPlace 3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics June 30, 2024 While their share prices have traveled different paths recently, the similarity between the two companies is striking. Via The Motley Fool If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy June 29, 2024 The market for weight loss medicines keeps getting hotter and hotter. Via The Motley Fool The 3 Smartest Biotech Stocks to Buy With $5K Right Now June 28, 2024 With global obesity numbers bursting at the seams, some of the smartest biotech stocks to buy are those with weight loss drugs. Via InvestorPlace Why Are Altimmune Shares Trading Lower Wednesday? June 26, 2024 Altimmune shares are experiencing significant movement lower following the unexpected passing of Richard Eisenstadt, the company's Chief Financial Officer. Via Benzinga Why Is Alimera Sciences (ALIM) Stock Up 77% Today? June 24, 2024 Alimera Sciences stock is up on Monday as investors react to a $5.50 per share acquisition offer for ALIM from ANI Pharmaceuticals. Via InvestorPlace BITF Stock Alert: Riot Platforms Is Changing Its Approach to Take Over Bitfarms June 24, 2024 Bitfarms stock is down on Monday after Riot Platforms withdrew its offer for BITF stock in favor of nominating new board memebers. Via InvestorPlace ALT Stock Alert: Altimmune Pops on Weight-Loss Drug Findings June 24, 2024 Altimmune (ALT) stock is soaring and trending after the company reported data on its GLP-1 weight-loss drug today. Via InvestorPlace Altimmune Stock Is Rising Monday: What's Driving The Action? June 24, 2024 Altimmune said it presented data from the 48-week Phase 2 MOMENTUM clinical trial of pemvidutide, including the results of a recently completed body composition analysis at the American Diabetes... Via Benzinga RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session June 24, 2024 Via Benzinga 3 Stocks Under $10 Set to Quadruple by 2025: June Edition June 13, 2024 Low-priced stocks under $10 can be explosively awarding if you spot the right one at the right time with the right catalyst. Via InvestorPlace 3 Stocks Quietly Preparing for a 10X Surge: June Edition June 12, 2024 There are plenty of 10x stocks with the potential to surge 10x over. We’ve already seen in happen with Apple, Netflix, Microsoft and Nvidia. Via InvestorPlace The 3 Most Undervalued Biotech Stocks to Buy in June 2024 June 04, 2024 https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate Via InvestorPlace The Penny Stock Prophecy: 3 Overlooked Stocks Primed to Pop May 27, 2024 Overlooked penny stocks are the path to outsized gains and these shares seem to fit the bill at the moment. Via InvestorPlace 3 Monster Stocks in the Making You Can Buy Right Now May 18, 2024 These stocks might not be small for too much longer. Via The Motley Fool < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
